United States Vaccine Market, Forecast By Type & Companies


Posted November 13, 2020 by PrateekRenub

United States Vaccine market will be US$ 11.4 Billion by 2026. Forecast By Type (Influenza, Retrovirus, Hepatitis, Polio, DTap, HIB, Pneumococcal Conjugate, Varicella, MMR and HPV), Products and Pipeline, Companies
 
The average human life span has grown significantly primarily due to vaccination. Vaccines have transformed public health throughout the world, especially for children. In the United States, among the various diseases like Influenza, Rotavirus, Hepatitis (Hepatitis A and Hepatitis B), Polio, DTap, HIB, Pneumococcal conjugate, Varicella, MMR and HPV, influenza is the most common viral infection. Quadrivalent is the most common flu vaccines in the United States, which was licensed in the year 2012. According to Renub Research, United States Vaccine Market is poised to reach US$ 11.4 Billion by 2026.

Follow the Link for Report Customization: https://www.renub.com/united-states-vaccine-market-p.php

Although influenza can catch anyone anytime in the year, usually it spreads between May to October. So in August National Immunization Awareness day is being celebrated to increase the awareness and the importance of vaccination in the nation. These immunizations awareness and government initiatives have helped to prevent 2-3 million deaths annually according to the World Health Organisation. There is no other health intervention as simple, powerful, and cost-effective as a ‘vaccine’.


In this report, we have studied key players like GlaxoSmithKline, plc, Merck & Co, Sanofi Pasteur and Pfizer, Inc their trends and implication which has given these companies to view in a strategic way. Apart from that, companies are evaluated on parameters like

• Overviews
• Recent Developments
• Revenues
• Vaccinations Pipeline & Clinical Trials


Renub Research report titled “United States Vaccine Market By Vaccine Type (Vaccines Market, Immunized Population and Administered Doses), Influenza (Trivalent Flu Vaccine and Quadrivalent Flu Vaccine), Retrovirus, Hepatitis (Hepatitis A and B), Polio, DTap, HIB, Pneumococcal Conjugate, Varicella, MMR and HPV) Vaccines Products and Pipeline, Company Analysis (GlaxoSmithKline, plc, Merck & Co, Sanofi Pasteur and Pfizer, Inc.)” provides an all-encompassing analysis on the United States Vaccine Industry.

Request a free Sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=united-states-vaccine-market-p.php

All the 10 Vaccines have been studied from 3 points

• Vaccines Market
• Immunized Population (Infants)
• Doses of Vaccines Administered


Vaccine Type - The Report Covers the Market, Immunized Population and Administered Doses of all the 10 diseases

1. Influenza Vaccines
2. Retrovirus
3. Hepatitis A & B
4. Polio
5. DTaP
6. HIB
7. Pneumococcal conjugate
8. Varicella
9. MMR
10. HPV


All the company analysis has been covered from 4 Viewpoints

• Overview
• Recent Developments
• Revenue Analysis
• Vaccinations Pipeline & Clinical Trials


Company Analysis

• GlaxoSmithKline, plc
• Merck & Co
• Sanofi Pasteur
• Pfizer, Inc.


About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.


Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email: [email protected]
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Renub Research
Phone +1 678-302-0700
Business Address Roswell, GA 30076
Country United States
Categories Health , Industry , Research
Tags industry research reports , market research reports , united states vaccine market , us vaccine market
Last Updated November 13, 2020